Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.
Saved in:
| Title: | Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. |
|---|---|
| Authors: | Burge DJ; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Eisenman J; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Byrnes-Blake K; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Smolak P; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Lau K; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Cohen SB; 2 Metroplex Clinical Research Center, Dallas, TX, USA., Kivitz AJ; 3 Altoona Center for Clinical Research, Duncansville, PA, USA., Levin R; 4 Clinical Research of West Florida, Clearwater, FL, USA., Martin RW; 5 Michigan State University, East Lansing, MI, USA., Sherrer Y; 6 Center for Rheumatology, Immunology, and Arthritis, Ft. Lauderdale, FL, USA., Posada JA; 1 Resolve Therapeutics, LLC, Seattle, WA, USA. |
| Source: | Lupus [Lupus] 2017 Jul; Vol. 26 (8), pp. 825-834. Date of Electronic Publication: 2016 Nov 16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27852935 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burge+DJ%22">Burge DJ</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Eisenman+J%22">Eisenman J</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Byrnes-Blake+K%22">Byrnes-Blake K</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Smolak+P%22">Smolak P</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Lau+K%22">Lau K</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+SB%22">Cohen SB</searchLink>; 2 Metroplex Clinical Research Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kivitz+AJ%22">Kivitz AJ</searchLink>; 3 Altoona Center for Clinical Research, Duncansville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Levin+R%22">Levin R</searchLink>; 4 Clinical Research of West Florida, Clearwater, FL, USA.<br /><searchLink fieldCode="AU" term="%22Martin+RW%22">Martin RW</searchLink>; 5 Michigan State University, East Lansing, MI, USA.<br /><searchLink fieldCode="AU" term="%22Sherrer+Y%22">Sherrer Y</searchLink>; 6 Center for Rheumatology, Immunology, and Arthritis, Ft. Lauderdale, FL, USA.<br /><searchLink fieldCode="AU" term="%22Posada+JA%22">Posada JA</searchLink>; 1 Resolve Therapeutics, LLC, Seattle, WA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229204265%22">Lupus</searchLink> [Lupus] 2017 Jul; Vol. 26 (8), pp. 825-834. <i>Date of Electronic Publication: </i>2016 Nov 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9204265 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0962 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209612033%22">09612033 </searchLink><i>NLM ISO Abbreviation: </i>Lupus <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27852935 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/0961203316678675 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 825 Titles: – TitleFull: Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burge DJ – PersonEntity: Name: NameFull: Eisenman J – PersonEntity: Name: NameFull: Byrnes-Blake K – PersonEntity: Name: NameFull: Smolak P – PersonEntity: Name: NameFull: Lau K – PersonEntity: Name: NameFull: Cohen SB – PersonEntity: Name: NameFull: Kivitz AJ – PersonEntity: Name: NameFull: Levin R – PersonEntity: Name: NameFull: Martin RW – PersonEntity: Name: NameFull: Sherrer Y – PersonEntity: Name: NameFull: Posada JA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2017 Jul Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1477-0962 Numbering: – Type: volume Value: 26 – Type: issue Value: 8 Titles: – TitleFull: Lupus Type: main |
| ResultId | 1 |